- Home
- AMZE vs LPCN Comparison
AMZE vs LPCN Comparison
Compare AMZE & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMZE
- LPCN
- Stock Information
- Founded
- AMZE 2019
- LPCN 1997
- Country
- AMZE United States
- LPCN United States
- Employees
- AMZE N/A
- LPCN N/A
- Industry
- AMZE Beverages (Production/Distribution)
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- AMZE Consumer Staples
- LPCN Health Care
- Exchange
- AMZE Nasdaq
- LPCN Nasdaq
- Market Cap
- AMZE 12.3M
- LPCN 14.3M
- IPO Year
- AMZE 2021
- LPCN N/A
- Fundamental
- Price
- AMZE $0.50
- LPCN $2.54
- Analyst Decision
- AMZE
- LPCN Strong Buy
- Analyst Count
- AMZE 0
- LPCN 1
- Target Price
- AMZE N/A
- LPCN $8.00
- AVG Volume (30 Days)
- AMZE 216.7K
- LPCN 32.9K
- Earning Date
- AMZE 11-14-2025
- LPCN 11-06-2025
- Dividend Yield
- AMZE N/A
- LPCN N/A
- EPS Growth
- AMZE N/A
- LPCN N/A
- EPS
- AMZE N/A
- LPCN N/A
- Revenue
- AMZE $1,054,111.00
- LPCN $4,322,693.00
- Revenue This Year
- AMZE $6,741.66
- LPCN N/A
- Revenue Next Year
- AMZE $100.61
- LPCN N/A
- P/E Ratio
- AMZE N/A
- LPCN N/A
- Revenue Growth
- AMZE N/A
- LPCN N/A
- 52 Week Low
- AMZE $0.48
- LPCN $2.52
- 52 Week High
- AMZE $22.54
- LPCN $6.16
- Technical
- Relative Strength Index (RSI)
- AMZE 23.16
- LPCN 34.84
- Support Level
- AMZE $1.00
- LPCN $2.52
- Resistance Level
- AMZE $0.95
- LPCN $2.77
- Average True Range (ATR)
- AMZE 0.15
- LPCN 0.13
- MACD
- AMZE -0.03
- LPCN -0.03
- Stochastic Oscillator
- AMZE 1.67
- LPCN 4.04
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.